Naoya Iwamoto

C4orf47 contributes to the dormancy of pancreatic cancer under hypoxic conditions

Masafumi Nakamura, Y. Oda, Shu Ichimiya, 2023, Journal of Cancer.

Tropomyosin-related Kinase B Is Potentially a Biomarker of Prognosis and Therapeutic Target for Malignant Thymic Epithelial Tumors

Masafumi Nakamura, Y. Oda, Katsuya Nakamura, 2022, AntiCancer Research.

C4orf47 Contributes to the Induction of Stem-like Properties in Gallbladder Cancer Under Hypoxia

H. Onishi, Shinji Morisaki, Shogo Masuda, 2023, AntiCancer Research.

PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer

A. Fujimura, Katsuya Nakamura, S. Nagai, 2022, AntiCancer Research.

Inhibition of PTPN3 Expressed in Activated Lymphocytes Enhances the Antitumor Effects of Anti-PD-1 Therapy in Head and Neck Cancer, Especially in Hypoxic Environments

A. Fujimura, Masayo Umebayashi, N. Komune, 2024, Journal of immunotherapy.

PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target

Masafumi Nakamura, Masayo Umebayashi, T. Morisaki, 2023, Journal of Cancer Research and Clinical Oncology.